Normal view
-
Cell
-
World models for biomedicine
Biological processes continuously adapt in response to intervention. Unlike static predictive models, biomedical world models support action-conditioned simulations for counterfactual reasoning, intervention design, and sequential planning. This perspective defines the key properties of biomedical world models and discusses the data, modeling, and evaluation challenges required to build them across biological and clinical scales.
-
Cell
-
Tahoe-100M: Mapping drug-induced molecular phenotypes at single-cell resolution
Tahoe-100M is an atlas of 100 million single-cell transcriptomes, capturing how 50 cancer cell lines respond to ∼1,100 drug-dose treatments. By pairing single-cell and molecular phenotypes at scale, the resource links drug mechanisms to cellular responses and provides an openly available substrate for training predictive models of cell behavior.
Tahoe-100M: Mapping drug-induced molecular phenotypes at single-cell resolution
-
Cell Death Discovery nature.com science feeds
-
rhNGF shows neuroprotective efficacy by counteracting oxidative stress and neuroinflammation in a glaucoma mouse model
Cell Death Discovery, Published online: 16 September 2026; doi:10.1038/s41420-026-03345-yrhNGF shows neuroprotective efficacy by counteracting oxidative stress and neuroinflammation in a glaucoma mouse model
rhNGF shows neuroprotective efficacy by counteracting oxidative stress and neuroinflammation in a glaucoma mouse model
Cell Death Discovery, Published online: 16 September 2026; doi:10.1038/s41420-026-03345-y
rhNGF shows neuroprotective efficacy by counteracting oxidative stress and neuroinflammation in a glaucoma mouse model-
Nature Medicine
-
Broadly neutralizing antibodies in adult males living with HIV undergoing analytical treatment interruption: secondary and exploratory outcomes of the phase II randomized controlled RIO trial
Nature Medicine, Published online: 15 September 2026; doi:10.1038/s41591-026-04644-8In the phase 2 RIO trial, there was delayed viral rebound and resistance to broadly neutralizing antibodies 3BNC117-LS and 10-1074-LS in adult males living with HIV undergoing analytical treatment interruption, and initial reservoir sensitivity to autologous antibodies was associated with a longer time to rebound.
Broadly neutralizing antibodies in adult males living with HIV undergoing analytical treatment interruption: secondary and exploratory outcomes of the phase II randomized controlled RIO trial
Nature Medicine, Published online: 15 September 2026; doi:10.1038/s41591-026-04644-8
In the phase 2 RIO trial, there was delayed viral rebound and resistance to broadly neutralizing antibodies 3BNC117-LS and 10-1074-LS in adult males living with HIV undergoing analytical treatment interruption, and initial reservoir sensitivity to autologous antibodies was associated with a longer time to rebound.-
Cell
-
The intrinsic cardiac nervous system is essential for cardiac function and survival
Two genetically distinct neuronal subtypes in the intrinsic cardiac nervous system are differentially required for baseline cardiac function and stress resilience to maintain cardiac stability and survival.
The intrinsic cardiac nervous system is essential for cardiac function and survival
-
Journal of Medical Internet Research
-
Anonymization of Portuguese Clinical Notes Using Large Language Models and Quantum-Enhanced Hybrid Architectures: Comparative Evaluation Study
Background: The widespread adoption of electronic health records (EHRs) has generated large-scale repositories of highly sensitive clinical information, emphasizing the need for robust anonymization strategies to enable secondary use for research while safeguarding patient privacy. Conventional rule-based and machine learning approaches for deidentifying medical text face limitations with the linguistic complexity, variability, and context dependence inherent to clinical documentation. Recent ad
Anonymization of Portuguese Clinical Notes Using Large Language Models and Quantum-Enhanced Hybrid Architectures: Comparative Evaluation Study
-
cs.AI, q-bio.NC updates on arXiv.org
-
Reproducing and Evaluating the Generalizability of Subliminal Learning in Open-Weight Models
arXiv:2609.12586v1 Announce Type: new Abstract: In this reproduction paper we investigate subliminal learning, a consequence of distillation where teacher models transmit behavioral preference traits through semantically unrelated data. The original paper explores two types of traits (animal preferences and misalignment), three data modalities (number sequences, code, and chain of thought), and several model families. We reproduce their experiments and extend the setup along three axes: new pre
Reproducing and Evaluating the Generalizability of Subliminal Learning in Open-Weight Models
-
cs.AI, q-bio.NC updates on arXiv.org
-
4D Parallelism Unlocks Exascale Bayesian Neural Networks for High-Fidelity Atmospheric Modeling
arXiv:2609.12815v1 Announce Type: cross Abstract: We present BEAST, the first-ever Bayesian Swin Transformer for atmospheric forecasting on 0.25$^\circ$ global resolution able to accurately quantify both aleatoric and epistemic uncertainty. To overcome the associated computational bottlenecks, we devise an orthogonal 4D-parallelization scheme that introduces a unique domain-tensor-parallelism strategy and a novel uncertainty parallel method, enabling us to fully leverage GPU capacity and effici
4D Parallelism Unlocks Exascale Bayesian Neural Networks for High-Fidelity Atmospheric Modeling
-
cs.AI, q-bio.NC updates on arXiv.org
-
PACE: A Neuro-Symbolic Framework for Plausible and Actionable Counterfactual Explanations
arXiv:2607.01306v2 Announce Type: replace Abstract: Counterfactual explanations explain machine learning predictions by identifying minimal input changes that would alter a model's decision. Although many existing methods successfully generate prediction-changing alternatives, they often produce unrealistic or infeasible recommendations due to a lack of explicit mechanisms for incorporating domain knowledge and intervention constraints. Neuro-symbolic AI offers a promising direction by combinin
PACE: A Neuro-Symbolic Framework for Plausible and Actionable Counterfactual Explanations
-
cs.AI, q-bio.NC updates on arXiv.org
-
The Vienna 4G/5G Drive-Test Dataset
arXiv:2603.02638v2 Announce Type: replace-cross Abstract: Machine learning for mobile network analysis, planning, and optimization is often limited by the lack of large, comprehensive real-world datasets. This paper introduces the Vienna 4G/5G Drive-Test Dataset, a city-scale open dataset of georeferenced Long Term Evolution (LTE) and 5G New Radio (NR) measurements collected across Vienna, Austria. The dataset combines passive wideband scanner observations with active handset logs, providing co
The Vienna 4G/5G Drive-Test Dataset
-
cs.AI, q-bio.NC updates on arXiv.org
-
ETHOS: Towards a Modular Ethics Framework for Clinical Multi-Agent Systems
arXiv:2608.15424v2 Announce Type: replace-cross Abstract: The rapid adoption of large language models has enabled the development of clinical multi-agent systems (MAS) capable of integrating multimodal patient data and supporting increasingly complex clinical decision-making. However, the deployment of these systems in real-world healthcare settings raises critical ethical concerns related to safety, fairness, accountability, transparency, and patient trust. While numerous organizations, includ
ETHOS: Towards a Modular Ethics Framework for Clinical Multi-Agent Systems
-
Nature - Issue - nature.com science feeds
-
Donor-funded science is rising in Brazil ― upending a long tradition
Nature, Published online: 14 September 2026; doi:10.1038/d41586-026-02829-2Philanthropists are stepping up support for research in a country where scientists have relied on the government alone for funding.
Donor-funded science is rising in Brazil ― upending a long tradition
Nature, Published online: 14 September 2026; doi:10.1038/d41586-026-02829-2
Philanthropists are stepping up support for research in a country where scientists have relied on the government alone for funding.-
Nature Cancer
-
Circulating tumor DNA-guided de-escalation or escalation of adjuvant therapy in high-risk stage II and stage III colon cancer: the phase 2 PEGASUS trial
Nature Cancer, Published online: 14 September 2026; doi:10.1038/s43018-026-01237-9Marsoni et al. evaluated the feasibility of a dynamic circulating tumor DNA-guided adjuvant and postadjuvant treatment strategy in patients with resected microsatellite-stable, high-risk stage II or III colon cancer in the phase 2 PEGASUS trial.
Circulating tumor DNA-guided de-escalation or escalation of adjuvant therapy in high-risk stage II and stage III colon cancer: the phase 2 PEGASUS trial
Nature Cancer, Published online: 14 September 2026; doi:10.1038/s43018-026-01237-9
Marsoni et al. evaluated the feasibility of a dynamic circulating tumor DNA-guided adjuvant and postadjuvant treatment strategy in patients with resected microsatellite-stable, high-risk stage II or III colon cancer in the phase 2 PEGASUS trial.-
Cell Death Discovery nature.com science feeds
-
HAT1 regulates glioblastoma cell proliferation and membrane lipid remodeling through ALDH2
Cell Death Discovery, Published online: 14 September 2026; doi:10.1038/s41420-026-03328-zHAT1 regulates glioblastoma cell proliferation and membrane lipid remodeling through ALDH2
HAT1 regulates glioblastoma cell proliferation and membrane lipid remodeling through ALDH2
Cell Death Discovery, Published online: 14 September 2026; doi:10.1038/s41420-026-03328-z
HAT1 regulates glioblastoma cell proliferation and membrane lipid remodeling through ALDH2-
TechCrunch
-
The 9 buzziest startups from Y Combinator’s latest Demo Day, according to VCs
From floating reactors to brain chips: VCs picked their favorite YC startups from the summer batch.
The 9 buzziest startups from Y Combinator’s latest Demo Day, according to VCs
-
Nature Biotechnology - Issue - nature.com science feeds
-
Biomimetic cells for studying T cell mechanotransduction
Nature Biotechnology, Published online: 10 September 2026; doi:10.1038/s41587-026-03312-zBiomimetic cells for studying T cell mechanotransduction
Biomimetic cells for studying T cell mechanotransduction
Nature Biotechnology, Published online: 10 September 2026; doi:10.1038/s41587-026-03312-z
Biomimetic cells for studying T cell mechanotransduction-
Nature Biotechnology - Issue - nature.com science feeds
-
AI-guided design of complete bacteriophage genomes
Nature Biotechnology, Published online: 10 September 2026; doi:10.1038/s41587-026-03311-0AI-guided design of complete bacteriophage genomes
AI-guided design of complete bacteriophage genomes
Nature Biotechnology, Published online: 10 September 2026; doi:10.1038/s41587-026-03311-0
AI-guided design of complete bacteriophage genomes-
Nature Biotechnology - Issue - nature.com science feeds
-
On-demand glycemic control by engineered bacteria
Nature Biotechnology, Published online: 10 September 2026; doi:10.1038/s41587-026-03323-wOn-demand glycemic control by engineered bacteria
On-demand glycemic control by engineered bacteria
Nature Biotechnology, Published online: 10 September 2026; doi:10.1038/s41587-026-03323-w
On-demand glycemic control by engineered bacteria-
Nature Medicine
-
Clinical usability of an explainable AI decision support tool and evaluation of multimodal models in NSCLC
Nature Medicine, Published online: 13 September 2026; doi:10.1038/s41591-026-04488-2In a large international real-world study of non-small cell lung cancer, a multimodal explainable AI model outperformed established biomarkers for immunotherapy outcome prediction and improved physician decision-making.
Clinical usability of an explainable AI decision support tool and evaluation of multimodal models in NSCLC
Nature Medicine, Published online: 13 September 2026; doi:10.1038/s41591-026-04488-2
In a large international real-world study of non-small cell lung cancer, a multimodal explainable AI model outperformed established biomarkers for immunotherapy outcome prediction and improved physician decision-making.-
MRD
-
The effect of unique molecular identifier family size using tumor-informed circulating tumor-DNA analysis in childhood cancers
J Mol Diagn. 2026 Sep 11:S1525-1578(26)00156-X. doi: 10.1016/j.jmoldx.2026.08.002. Online ahead of print.ABSTRACTAnalysis of circulating tumor-DNA (ctDNA) provides a molecular assessment that can complement routine imaging in childhood cancer management. Detailed monitoring of ctDNA levels may provide information on treatment efficacy and resistance, minimal residual disease and allows for early detection of relapse. Here, tumor-informed ctDNA analysis was applied to 90 blood plasma samples coll
The effect of unique molecular identifier family size using tumor-informed circulating tumor-DNA analysis in childhood cancers
J Mol Diagn. 2026 Sep 11:S1525-1578(26)00156-X. doi: 10.1016/j.jmoldx.2026.08.002. Online ahead of print.
ABSTRACT
Analysis of circulating tumor-DNA (ctDNA) provides a molecular assessment that can complement routine imaging in childhood cancer management. Detailed monitoring of ctDNA levels may provide information on treatment efficacy and resistance, minimal residual disease and allows for early detection of relapse. Here, tumor-informed ctDNA analysis was applied to 90 blood plasma samples collected from eight children with malignant tumors. Four to ten tumor-specific mutations per patient were assessed using SiMSen-Seq, a digital sequencing approach utilizing unique molecular identifiers (UMIs). The effects of individual SiMSen-Seq assays and plasma samples were evaluated in relation to their impact on background error rate, number of detected target molecules and mutant calling using different UMI family size cutoff settings. The use of at least two sequencing reads per UMI provided the best overall performance by generating the highest number of detected target molecules and hence the optimal chance to detect low-frequent mutations. Data were consistent between SiMSen-Seq assays and plasma samples, providing robust ctDNA profiling over time for all patients. In conclusion, the results show that optimal use of UMIs in tumor-informed ctDNA analysis enables sensitive molecular readout that can assist in management of childhood cancers.
PMID:42727690 | DOI:10.1016/j.jmoldx.2026.08.002